Carlene Muto, MD, MS, Medical Director of Infection Prevention and Control for Temple Health, provided perspective for an Everyday Health article about the U.S. Food and Drug Administration’s approval of FluMist for self- or caregiver-administration. FluMist is a nasal spray version of the flu vaccine and is approved for use in individuals 2 to 49 years old. It is the first vaccine to prevent the flu that does not need to be administered by a health care provider.
Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH